Sequential therapy with saratin, bevacizumab and ilomastat to prolong bleb function following glaucoma filtration surgery in a rabbit model

Medicine & Life Sciences

• saratin 100%
• ilomastat 86%
• Filtering Surgery 63%
• Bevacizumab 49%
• Blister 47%
• Glaucoma 42%
• Rabbits 31%
• Saline Solution 23%
• Mitomycin 21%
• Eye 18%
• Fibrosis 14%
• Injections 14%
• Capsules 8%
• Histology 7%
• Therapeutics 7%
• Matrix Metalloproteinase Inhibitors 5%
• Control Groups 5%
• Vascular Endothelial Growth Factor A 4%
• Analysis of Variance 3%
• Anti-Inflammatory Agents 3%
• Monoclonal Antibodies 3%
• Peptides 3%

Agriculture & Biology

• glaucoma 62%
• surgery 44%
• mitomycin 36%
• fibrosis 36%
• eyes 34%
• therapeutics 34%
• sodium chloride 33%
• rabbits 29%
• injection 25%
• histology 14%
• tissues 9%
• angiogenesis 9%
• New Zealand White rabbit 8%
• metalloproteinases 8%
• adverse effects 6%
• analysis of variance 6%
• polypeptides 5%
• antibodies 4%
• testing 2%

Chemical Compounds

• Ilomastat 95%
• Mitomycin C 41%
• Filtration 38%
• Time 13%
• Matrix Metalloproteinase Inhibitor 11%
• Fibrous Crystal 7%
• Antiinflammatory 7%
• White 6%
• Polypeptide 6%
• Block Like Crystal 5%
• Surface 2%